Most patients are advised to maintain a stable weight for several months before pursuing facial surgery, body contouring, or breast procedures
Weight loss can vary widely among individuals, but many people lose between 5% to 10% of their body weight over six months to a year
The guides on transitioning from tirzepatide to retatrutide and retatrutide onset after tirzepatide address these scenarios with specific timeline and dosing recommendations
Flexibility in Treatment Micro-dosing allows for a high degree of flexibility, enabling healthcare providers to adjust doses based on patient response
Short-acting GLP-1 receptor agonists include exenatide (Byetta, with limited US availability) and lixisenatide (Adlyxin, discontinued in the US market)
Incorporate: Aerobic exercise, such as brisk walking, jogging or swimming, three to five times per week Resistance training, such as weightlifting and bodyweight exercises, two to three times a week Prioritize sleep
